Atyr Pharma Inc (NASDAQ: ATYR) kicked off on Friday, down -8.93% from the previous trading day, before settling in for the closing price of $3.19. Over the past 52 weeks, ATYR has traded in a range of $1.09-$3.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 436.18%. While this was happening, its average annual earnings per share was recorded 2.28%. With a float of $81.75 million, this company’s outstanding shares have now reached $83.94 million.
The extent of productivity of a business whose workforce counts for 59 workers is very important to gauge. In terms of profitability, gross margin is -563.83%, operating margin of -28958.72%, and the pretax margin is -27155.32%.
Atyr Pharma Inc (ATYR) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Atyr Pharma Inc is 2.61%, while institutional ownership is 63.05%. The most recent insider transaction that took place on Jul 24 ’24, was worth 101,038. In this transaction Director of this company bought 52,300 shares at a rate of $1.93, taking the stock ownership to the 413,023 shares. Before that another transaction happened on Jul 22 ’24, when Company’s Director bought 41,052 for $1.74, making the entire transaction worth $71,500. This insider now owns 354,075 shares in total.
Atyr Pharma Inc (ATYR) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.25 earnings per share (EPS), lower than consensus estimate (set at -0.24) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to 43.36% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Take a look at Atyr Pharma Inc’s (ATYR) current performance indicators. Last quarter, stock had a quick ratio of 5.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 965.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.81 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
The latest stats from [Atyr Pharma Inc, ATYR] show that its last 5-days average volume of 1.0 million was superior to 0.57 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 37.61%. Additionally, its Average True Range was 0.26.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 61.59%, which indicates a significant increase from 9.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.01% in the past 14 days, which was higher than the 73.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.49, while its 200-day Moving Average is $1.97. Now, the first resistance to watch is $3.10. This is followed by the second major resistance level at $3.30. The third major resistance level sits at $3.44. If the price goes on to break the first support level at $2.76, it is likely to go to the next support level at $2.61. The third support level lies at $2.42 if the price breaches the second support level.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
The company with the Market Capitalisation of 222.06 million has total of 83,942K Shares Outstanding. Its annual sales at the moment are 350 K in contrast with the sum of -50,390 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -16,310 K.
